974 Results

People

  1. De Angelis
    De Angelis
  2. Yahalom
    Yahalom
  3. Abrey
    Abrey
  4. Zelenetz
    Zelenetz
  5. Perales
    Perales
  6. Horwitz
    Horwitz
  7. Schoder
    Schoder
  8. Moskowitz
    Moskowitz
  9. Noy
    Noy
  10. Portlock
    Portlock

Groups

  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)
  7. Tow Center for Developmental Oncology (TCDO) (139)
  8. Sloan Kettering Institute Faculty (133)
  9. Radiology, Department of (99)
  10. Population Sciences Research Program (94)
  1. "lymphoma"
Formats
  1. Journal Article (854)
  2. Review (54)
  3. Conference Paper (13)
  4. Editorial (13)
  5. Meeting Abstract (11)
  6. Research Letter (11)
  7. Book Section (9)
  8. Correspondence (4)
  9. Guidelines (3)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (413)
  2. Hematologic Malignancies, Division of (317)
  3. Center for Hematologic Malignancies (307)
  4. Lymphoma (162)
  5. GSK Faculty (154)
  6. Survivorship Research (142)

More Groups

People
  1. Lisa De Angelis (69)
  2. Joachim Yahalom (46)
  3. Lauren Abrey (41)
  4. Andrew Zelenetz (40)
  5. Miguel-Angel Perales (31)
  6. Steven Horwitz (28)

More People

Years
  1. 2025 (21)
  2. 2024 (43)
  3. 2023 (40)
  4. 2022 (38)
  5. 2021 (21)
  6. 2020 (36)

More Years

Publications
  1. Journal of Clinical Oncology (38)
  2. Cancer (36)
  3. Leukemia and Lymphoma (36)
  4. Blood (35)
  5. Biology of Blood and Marrow Transplantation (21)
  6. Annals of Oncology (19)

More Publications

Publishers
  1. Elsevier Inc. (127)
  2. Springer (68)
  3. Wiley Blackwell (64)
  4. Lippincott Williams & Wilkins (62)
  5. Nature Publishing Group (53)
  6. American Society of Clinical Oncology (45)

More Publishers

Results (974)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Indolent lymphomas: Introduction to a series highlighting progress and ongoing challenges
    Review

    Smith, S. M.; Salles, G.
    Haematologica (2022)

    Fulltext@MSK | Save
  • Prolonged SARS-CoV-2 infection in patients with lymphoid malignancies
    Journal Article

    Lee, C. Y.; Shah, M. K.; Hoyos, D.; Solovyov, A.; Douglas, M.; Taur, Y.; Maslak, P.; Babady, N. E.; Greenbaum, B.; Kamboj, M.; more...
    Cancer Discovery (2022)

    Fulltext@MSK | Save
  • Incorporation of bacterial immunoevasins to protect cell therapies from host antibody-mediated immune rejection
    Journal Article

    Peraro, L.; Bourne, C. M.; Dacek, M. M.; Akalin, E.; Park, J. H.; Smith, E. L.; Scheinberg, D. A.
    Molecular Therapy (2021)

    Fulltext@MSK | Save
  • Challenges and opportunities in 2021
    Editorial

    Akkari, L.; Finley, S. D.; Ho, P. C.; Jenkins, M.; Maier, B. B.; McGranahan, N.; Mutebi, M.; Perera, R. M.; Robles-Espinoza, C. D.; Vardhana, S.; more...
    Nature Cancer (2021)

    Fulltext@MSK | Save
  • Primary cutaneous T-cell lymphomas other than mycosis fungoides and Sézary syndrome. Part I: Clinical and histologic features and diagnosis
    Review

    Stoll, J. R.; Willner, J.; Oh, Y.; Pulitzer, M.; Moskowitz, A.; Horwitz, S.; Myskowski, P.; Noor, S. J.
    Journal of the American Academy of Dermatology (2021)

    Fulltext@MSK | Save
  • The role of (18)F-FDG PET/CT radiomics in lymphoma
    Review

    Rizzo, A.; Triumbari, E. K. A.; Gatta, R.; Boldrini, L.; Racca, M.; Mayerhoefer, M.; Annunziata, S.
    Clinical and Translational Imaging (2021)

    Fulltext@MSK | Save
  • Lymphoma: Advances in imaging and radiotherapy – Introductory editorial
    Editorial

    Illidge, T.; Mikhaeel, N. G.; Specht, L.; Yahalom, J.
    British Journal of Radiology (2021)

    Fulltext@MSK | Save
  • Balancing the CAR T: Perspectives on efficacy and safety of CAR T-cell therapy in hematologic malignancies
    Review

    Buie, L. W.
    American Journal of Managed Care (2021)

    Fulltext@MSK | Save
  • Overall survival with tafasitamab + lenalidomide (LEN) vs routinely administered therapies for ASCT-ineligible relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL): Outcomes from the observational RE-MIND2 study
    Meeting Abstract

    Nowakowski, G. S.; Yoon, D. H.; Mondello, P.; Joffe, E.; Peters, A.; Fleury, I.; Greil, R.; Ku, M.; Marks, R.; Kim, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2021)

    Fulltext@MSK | Save
  • Prognostic value of baseline metabolic tumor volume in children and adolescents with intermediate-risk Hodgkin lymphoma treated with chemo-radiation therapy: FDG-PET parameter analysis in a subgroup from COG AHOD0031
    Journal Article

    Milgrom, S. A.; Kim, J.; Chirindel, A.; Kim, J.; Pei, Q.; Chen, L.; Buxton, A.; Kessel, S.; Leal, J.; McCarten, K. M.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save